Literature DB >> 3259972

Reversible biotinylation of C1q with a cleavable biotinyl derivative. Application in C1q receptor (C1qR) purification.

B Ghebrehiwet1, S Bossone, A Erdei, K B Reid.   

Abstract

Reversible biotinylation of human C1q without impairment of its physiologic functions has allowed us to develop a simple and rapid purification method for C1q receptor (C1qR). The biotinylating reagent, NHS-SS-biotin (Mr 606.7) contains an extended connector or cross-linker arm which limits steric hindrance and is bridged by a cleavable disulfide bond to the biotin component. Biotinylation was achieved by mixing C1q (in PBS, pH 7.4) with NHS-SS-biotin (dissolved in dimethyl formamide) in a 50:1 v/v and 1:25 mol/mol ratio and allowing the reaction to continue at room temperature for 4 h. The mixture was then dialyzed against PBS pH 7.4 (2 X 1 liter) and analyzed by SDS-PAGE and hemolytic assay using C1q depleted serum. Under these conditions neither denaturation of the protein nor loss of hemolytic activity was evident. Such biotinylated C1q (Bio-C1q) was used to pull out the C1qR from detergent-solubilized (1% NP-40 in PBS, pH 7.4 plus inhibitors) 125I-surface labeled membrane solution that had been first centrifuged (1 h, 45,000 X g, 4 degrees C) and then sequentially precleared with immobilized protein A, protein A-IgG and gelatin. The mixture of Bio-C1q and membrane solution was then incubated (20 h, 4 degrees C), applied to immobilized avidin (equilibrated with PBS, pH 7.4, 0.1% NP-40) and after washing, the bound C1qR was eluted with equilibrating buffer containing 1 M NaCl, and the C1q by same buffer containing 100 mM DTT. The eluted C1qR contained a major Mr 70,000 molecule which upon reduction electrophoresed with an apparent Mr of 85,000-90,000 as assessed by SDS-PAGE analysis. In addition, a faint single chain band of 30-40 kDa was eluted with the major band and may represent a non-covalently associated part of the C1qR molecule.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3259972     DOI: 10.1016/0022-1759(88)90111-1

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  6 in total

1.  C1q binding and activation of the complement classical pathway by Klebsiella pneumoniae outer membrane proteins.

Authors:  S Albertí; G Marqués; S Camprubí; S Merino; J M Tomás; F Vivanco; V J Benedí
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

2.  Identification of a gC1q-binding protein (gC1q-R) on the surface of human neutrophils. Subcellular localization and binding properties in comparison with the cC1q-R.

Authors:  P Eggleton; B Ghebrehiwet; K N Sastry; J P Coburn; K S Zaner; K B Reid; A I Tauber
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

3.  A functional YNKI motif in the short cytoplasmic tail of varicella-zoster virus glycoprotein gH mediates clathrin-dependent and antibody-independent endocytosis.

Authors:  Tracy Jo Pasieka; Lucie Maresova; Charles Grose
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

4.  Bound fibrinogen distribution on stimulated platelets. Examination by confocal scanning laser microscopy.

Authors:  E I Peerschke
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

5.  Quantitation of estradiol by competitive light-initiated chemiluminescent assay using estriol as competitive antigen.

Authors:  Jiuzhi Li; Liuxu Li; Ying Bian; Yang Yu; Zhonghua Qiang; Yuexiang Zhang; Huiqiang Li
Journal:  J Clin Lab Anal       Date:  2019-08-24       Impact factor: 2.352

6.  Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q.

Authors:  B Ghebrehiwet; B L Lim; E I Peerschke; A C Willis; K B Reid
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.